nodes	percent_of_prediction	percent_of_DWPC	metapath
Pheniramine—Benzphetamine—obesity	0.579	1	CrCtD
Pheniramine—Tropicamide—Benzphetamine—obesity	0.0506	0.128	CrCrCtD
Pheniramine—Phenprocoumon—Benzphetamine—obesity	0.0257	0.0651	CrCrCtD
Pheniramine—Methadyl Acetate—Benzphetamine—obesity	0.0224	0.0566	CrCrCtD
Pheniramine—Levomethadyl Acetate—Benzphetamine—obesity	0.0224	0.0566	CrCrCtD
Pheniramine—Cyclobenzaprine—Benzphetamine—obesity	0.021	0.0532	CrCrCtD
Pheniramine—Doxylamine—Benzphetamine—obesity	0.0193	0.0489	CrCrCtD
Pheniramine—Dextropropoxyphene—Benzphetamine—obesity	0.0183	0.0465	CrCrCtD
Pheniramine—Phenoxybenzamine—Benzphetamine—obesity	0.0183	0.0465	CrCrCtD
Pheniramine—Tripelennamine—Benzphetamine—obesity	0.0175	0.0443	CrCrCtD
Pheniramine—Atomoxetine—Benzphetamine—obesity	0.0175	0.0443	CrCrCtD
Pheniramine—Modafinil—Benzphetamine—obesity	0.0171	0.0433	CrCrCtD
Pheniramine—Trimipramine—Benzphetamine—obesity	0.0171	0.0433	CrCrCtD
Pheniramine—Bromodiphenhydramine—Benzphetamine—obesity	0.0163	0.0414	CrCrCtD
Pheniramine—Benzphetamine—Methamphetamine—obesity	0.0162	0.041	CrCrCtD
Pheniramine—Cyclizine—Benzphetamine—obesity	0.0157	0.0397	CrCrCtD
Pheniramine—Methadone—Benzphetamine—obesity	0.0153	0.0389	CrCrCtD
Pheniramine—Alimemazine—Benzphetamine—obesity	0.0142	0.036	CrCrCtD
Pheniramine—Clofedanol—Benzphetamine—obesity	0.0133	0.0336	CrCrCtD
Pheniramine—Orphenadrine—Benzphetamine—obesity	0.0128	0.0325	CrCrCtD
Pheniramine—Promazine—Benzphetamine—obesity	0.0123	0.031	CrCrCtD
Pheniramine—Diphenhydramine—Benzphetamine—obesity	0.0114	0.0289	CrCrCtD
Pheniramine—Atomoxetine—NPY1R—obesity	0.00031	0.115	CrCbGaD
Pheniramine—Amitriptyline—NTRK2—obesity	0.00016	0.0594	CrCbGaD
Pheniramine—Cyclopentolate—BCHE—obesity	0.000149	0.0554	CrCbGaD
Pheniramine—Captodiame—HTR2C—obesity	0.000145	0.0539	CrCbGaD
Pheniramine—Disopyramide—SLC22A1—obesity	0.000128	0.0476	CrCbGaD
Pheniramine—Chlorphenamine—SLC22A1—obesity	9.33e-05	0.0348	CrCbGaD
Pheniramine—Levomethadyl Acetate—CYP19A1—obesity	7.75e-05	0.0289	CrCbGaD
Pheniramine—Phenoxybenzamine—SLC22A1—obesity	7.55e-05	0.0281	CrCbGaD
Pheniramine—Atomoxetine—HTR1B—obesity	6.72e-05	0.025	CrCbGaD
Pheniramine—Diphenhydramine—SLC22A1—obesity	6.33e-05	0.0236	CrCbGaD
Pheniramine—Carbinoxamine—CYP2E1—obesity	6.08e-05	0.0227	CrCbGaD
Pheniramine—Cyclobenzaprine—HTR2A—obesity	5.94e-05	0.0221	CrCbGaD
Pheniramine—Atomoxetine—HTR2C—obesity	5.48e-05	0.0204	CrCbGaD
Pheniramine—Chlorphenamine—SLC6A4—obesity	5.4e-05	0.0201	CrCbGaD
Pheniramine—Promazine—DRD4—obesity	5.27e-05	0.0196	CrCbGaD
Pheniramine—Brompheniramine—CYP2E1—obesity	5.27e-05	0.0196	CrCbGaD
Pheniramine—Phenoxybenzamine—ADRB2—obesity	4.82e-05	0.0179	CrCbGaD
Pheniramine—Imipramine—SLC22A1—obesity	4.78e-05	0.0178	CrCbGaD
Pheniramine—Methadone—CYP19A1—obesity	4.54e-05	0.0169	CrCbGaD
Pheniramine—Atomoxetine—SLC6A4—obesity	4.54e-05	0.0169	CrCbGaD
Pheniramine—Trimipramine—HTR2C—obesity	4.51e-05	0.0168	CrCbGaD
Pheniramine—Promazine—DRD1—obesity	4.46e-05	0.0166	CrCbGaD
Pheniramine—Doxepin—HTR2C—obesity	4.3e-05	0.016	CrCbGaD
Pheniramine—Amitriptyline—HTR1B—obesity	4.08e-05	0.0152	CrCbGaD
Pheniramine—Phenprocoumon—ALB—obesity	3.82e-05	0.0142	CrCbGaD
Pheniramine—Promazine—HTR2C—obesity	3.82e-05	0.0142	CrCbGaD
Pheniramine—HRH1—GPCR downstream signaling—NMU—obesity	3.74e-05	0.0016	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—PMCH—obesity	3.74e-05	0.0016	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—NPY5R—obesity	3.74e-05	0.0016	CbGpPWpGaD
Pheniramine—Trimipramine—SLC6A4—obesity	3.74e-05	0.0139	CrCbGaD
Pheniramine—Trimipramine—DRD2—obesity	3.71e-05	0.0138	CrCbGaD
Pheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—obesity	3.69e-05	0.00158	CbGpPWpGaD
Pheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB2—obesity	3.69e-05	0.00158	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—KIF7—obesity	3.66e-05	0.00157	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—MKS1—obesity	3.66e-05	0.00157	CbGpPWpGaD
Pheniramine—HRH1—GPCR ligand binding—NPS—obesity	3.65e-05	0.00156	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—NPY1R—obesity	3.59e-05	0.00153	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—NPY2R—obesity	3.59e-05	0.00153	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—MC4R—obesity	3.59e-05	0.00153	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—MC3R—obesity	3.59e-05	0.00153	CbGpPWpGaD
Pheniramine—HRH1—GPCR ligand binding—DRD1—obesity	3.58e-05	0.00153	CbGpPWpGaD
Pheniramine—HRH1—GPCR ligand binding—HTR2C—obesity	3.58e-05	0.00153	CbGpPWpGaD
Pheniramine—Doxepin—SLC6A4—obesity	3.56e-05	0.0133	CrCbGaD
Pheniramine—Doxepin—DRD2—obesity	3.54e-05	0.0132	CrCbGaD
Pheniramine—HRH1—GPCR downstream signaling—PPY—obesity	3.52e-05	0.00151	CbGpPWpGaD
Pheniramine—Atomoxetine—HTR2A—obesity	3.49e-05	0.013	CrCbGaD
Pheniramine—HRH1—GPCR ligand binding—ADRB1—obesity	3.46e-05	0.00148	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—PRKCH—obesity	3.45e-05	0.00148	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—GIP—obesity	3.45e-05	0.00148	CbGpPWpGaD
Pheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—obesity	3.41e-05	0.00146	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—NMU—obesity	3.4e-05	0.00145	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—PMCH—obesity	3.4e-05	0.00145	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—NPY5R—obesity	3.4e-05	0.00145	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—HCRT—obesity	3.4e-05	0.00145	CbGpPWpGaD
Pheniramine—HRH1—GPCR ligand binding—GHRL—obesity	3.39e-05	0.00145	CbGpPWpGaD
Pheniramine—Warfarin—ALB—obesity	3.39e-05	0.0126	CrCbGaD
Pheniramine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—obesity	3.36e-05	0.00144	CbGpPWpGaD
Pheniramine—HRH1—GPCR ligand binding—DRD4—obesity	3.36e-05	0.00144	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—PRLH—obesity	3.35e-05	0.00143	CbGpPWpGaD
Pheniramine—Imipramine—HTR2C—obesity	3.34e-05	0.0125	CrCbGaD
Pheniramine—Amitriptyline—HTR2C—obesity	3.32e-05	0.0124	CrCbGaD
Pheniramine—Orphenadrine—CYP2E1—obesity	3.32e-05	0.0124	CrCbGaD
Pheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL5—obesity	3.27e-05	0.0014	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—NPY2R—obesity	3.26e-05	0.00139	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—NPY1R—obesity	3.26e-05	0.00139	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—MC4R—obesity	3.26e-05	0.00139	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—MC3R—obesity	3.26e-05	0.00139	CbGpPWpGaD
Pheniramine—HRH1—GPCR ligand binding—CNR1—obesity	3.21e-05	0.00137	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—PPY—obesity	3.2e-05	0.00137	CbGpPWpGaD
Pheniramine—Promazine—DRD2—obesity	3.15e-05	0.0117	CrCbGaD
Pheniramine—HRH1—Signaling by GPCR—PRKCH—obesity	3.14e-05	0.00134	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—GIP—obesity	3.14e-05	0.00134	CbGpPWpGaD
Pheniramine—HRH1—GPCR ligand binding—DRD2—obesity	3.13e-05	0.00134	CbGpPWpGaD
Pheniramine—HRH1—GPCR ligand binding—GCG—obesity	3.1e-05	0.00133	CbGpPWpGaD
Pheniramine—HRH1—G alpha (q) signalling events—PIK3R1—obesity	3.03e-05	0.0013	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—ADRB3—obesity	2.94e-05	0.00126	CbGpPWpGaD
Pheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—obesity	2.88e-05	0.00123	CbGpPWpGaD
Pheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—C3—obesity	2.88e-05	0.00123	CbGpPWpGaD
Pheniramine—Trimipramine—HTR2A—obesity	2.87e-05	0.0107	CrCbGaD
Pheniramine—HRH1—GPCR downstream signaling—GAL—obesity	2.87e-05	0.00123	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—C5AR1—obesity	2.84e-05	0.00121	CbGpPWpGaD
Pheniramine—HRH1—GPCR ligand binding—ADRB2—obesity	2.81e-05	0.0012	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—NMB—obesity	2.78e-05	0.00119	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—GHRH—obesity	2.78e-05	0.00119	CbGpPWpGaD
Pheniramine—Imipramine—SLC6A4—obesity	2.77e-05	0.0103	CrCbGaD
Pheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—obesity	2.76e-05	0.00118	CbGpPWpGaD
Pheniramine—Imipramine—DRD2—obesity	2.75e-05	0.0103	CrCbGaD
Pheniramine—Amitriptyline—SLC6A4—obesity	2.75e-05	0.0103	CrCbGaD
Pheniramine—Amitriptyline—DRD2—obesity	2.74e-05	0.0102	CrCbGaD
Pheniramine—Doxepin—HTR2A—obesity	2.74e-05	0.0102	CrCbGaD
Pheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—AGT—obesity	2.73e-05	0.00117	CbGpPWpGaD
Pheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3R1—obesity	2.71e-05	0.00116	CbGpPWpGaD
Pheniramine—HRH1—GPCR ligand binding—GNB3—obesity	2.67e-05	0.00114	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—ADRB3—obesity	2.67e-05	0.00114	CbGpPWpGaD
Pheniramine—Imipramine—CYP2E1—obesity	2.65e-05	0.00988	CrCbGaD
Pheniramine—HRH1—Signaling Pathways—FFAR4—obesity	2.65e-05	0.00113	CbGpPWpGaD
Pheniramine—Amitriptyline—CYP2E1—obesity	2.64e-05	0.00982	CrCbGaD
Pheniramine—HRH1—Signaling by GPCR—GAL—obesity	2.61e-05	0.00111	CbGpPWpGaD
Pheniramine—HRH1—GPCR ligand binding—GNAS—obesity	2.6e-05	0.00111	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—CCK—obesity	2.59e-05	0.00111	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—C5AR1—obesity	2.58e-05	0.0011	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—MCHR1—obesity	2.54e-05	0.00109	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—GHSR—obesity	2.54e-05	0.00109	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—BRS3—obesity	2.54e-05	0.00109	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—GLP1R—obesity	2.53e-05	0.00108	CbGpPWpGaD
Pheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—F2—obesity	2.53e-05	0.00108	CbGpPWpGaD
Pheniramine—HRH1—GPCR ligand binding—CCL5—obesity	2.49e-05	0.00106	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—CCKAR—obesity	2.49e-05	0.00106	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—HRH3—obesity	2.49e-05	0.00106	CbGpPWpGaD
Pheniramine—Promazine—HTR2A—obesity	2.43e-05	0.00906	CrCbGaD
Pheniramine—HRH1—Signaling Pathways—SH2B1—obesity	2.36e-05	0.00101	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—PRLHR—obesity	2.36e-05	0.00101	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—GH1—obesity	2.36e-05	0.00101	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—CCK—obesity	2.36e-05	0.00101	CbGpPWpGaD
Pheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—obesity	2.3e-05	0.000984	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—GLP1R—obesity	2.3e-05	0.000982	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—HRH3—obesity	2.26e-05	0.000966	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—CCKAR—obesity	2.26e-05	0.000966	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—NPY—obesity	2.25e-05	0.000964	CbGpPWpGaD
Pheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—obesity	2.25e-05	0.000963	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—IAPP—obesity	2.24e-05	0.000958	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—PYY—obesity	2.22e-05	0.00095	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—APLN—obesity	2.22e-05	0.00095	CbGpPWpGaD
Pheniramine—HRH1—GPCR ligand binding—HTR2A—obesity	2.19e-05	0.000938	CbGpPWpGaD
Pheniramine—HRH1—GPCR ligand binding—C3—obesity	2.19e-05	0.000937	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—PRKAR2B—obesity	2.17e-05	0.00093	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—HTR1B—obesity	2.17e-05	0.00093	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—CRH—obesity	2.17e-05	0.00093	CbGpPWpGaD
Pheniramine—Imipramine—HTR2A—obesity	2.13e-05	0.00793	CrCbGaD
Pheniramine—Amitriptyline—HTR2A—obesity	2.12e-05	0.00788	CrCbGaD
Pheniramine—HRH1—Signaling Pathways—PNLIP—obesity	2.1e-05	0.0009	CbGpPWpGaD
Pheniramine—HRH1—GPCR ligand binding—AGT—obesity	2.08e-05	0.00089	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—NPS—obesity	2.06e-05	0.000882	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—SDC3—obesity	2.05e-05	0.000879	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—NPY—obesity	2.05e-05	0.000875	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—IAPP—obesity	2.03e-05	0.00087	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—HTR2C—obesity	2.02e-05	0.000865	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—DRD1—obesity	2.02e-05	0.000865	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—NPY5R—obesity	2.01e-05	0.000859	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—PMCH—obesity	2.01e-05	0.000859	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—NMU—obesity	2.01e-05	0.000859	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—HCRT—obesity	2.01e-05	0.000859	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—CRH—obesity	1.97e-05	0.000844	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—HTR1B—obesity	1.97e-05	0.000844	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—ADRB1—obesity	1.96e-05	0.000837	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—NPY1R—obesity	1.93e-05	0.000823	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—NPY2R—obesity	1.93e-05	0.000823	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—MC4R—obesity	1.93e-05	0.000823	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—MC3R—obesity	1.93e-05	0.000823	CbGpPWpGaD
Pheniramine—HRH1—GPCR ligand binding—F2—obesity	1.92e-05	0.000823	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—GHRL—obesity	1.92e-05	0.00082	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—DRD4—obesity	1.9e-05	0.000813	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—PPY—obesity	1.89e-05	0.000807	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—NPS—obesity	1.87e-05	0.000801	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—PRKCH—obesity	1.85e-05	0.000793	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—HDAC8—obesity	1.85e-05	0.000793	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—GIP—obesity	1.85e-05	0.000793	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—DRD1—obesity	1.84e-05	0.000785	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—HTR2C—obesity	1.84e-05	0.000785	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—CNR1—obesity	1.81e-05	0.000776	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—ADRB1—obesity	1.78e-05	0.00076	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—DRD2—obesity	1.77e-05	0.000757	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—LEPR—obesity	1.76e-05	0.000753	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—GCG—obesity	1.75e-05	0.00075	CbGpPWpGaD
Pheniramine—HRH1—GPCR ligand binding—POMC—obesity	1.75e-05	0.000749	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—GHRL—obesity	1.74e-05	0.000744	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—DRD4—obesity	1.73e-05	0.000738	CbGpPWpGaD
Pheniramine—HRH1—GPCR ligand binding—CCL2—obesity	1.71e-05	0.000733	CbGpPWpGaD
Pheniramine—HRH1—G alpha (q) signalling events—PIK3CA—obesity	1.71e-05	0.000729	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—CNR1—obesity	1.65e-05	0.000705	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—DRD2—obesity	1.61e-05	0.000688	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—GCG—obesity	1.59e-05	0.000681	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—ADRB2—obesity	1.59e-05	0.000678	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—ADRB3—obesity	1.58e-05	0.000674	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—GAL—obesity	1.54e-05	0.000658	CbGpPWpGaD
Pheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—obesity	1.52e-05	0.000652	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—C5AR1—obesity	1.52e-05	0.000651	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—GNB3—obesity	1.51e-05	0.000646	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—GNAS—obesity	1.47e-05	0.000629	CbGpPWpGaD
Pheniramine—Amitriptyline—ALB—obesity	1.45e-05	0.00539	CrCbGaD
Pheniramine—HRH1—Signaling by GPCR—ADRB2—obesity	1.44e-05	0.000616	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—CCL5—obesity	1.41e-05	0.000602	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—CCK—obesity	1.39e-05	0.000595	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—PRKG1—obesity	1.39e-05	0.000595	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—GNB3—obesity	1.37e-05	0.000587	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—RBP4—obesity	1.36e-05	0.00058	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—GLP1R—obesity	1.36e-05	0.00058	CbGpPWpGaD
Pheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—obesity	1.35e-05	0.000578	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—GNAS—obesity	1.34e-05	0.000571	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—CCKAR—obesity	1.33e-05	0.000571	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—HRH3—obesity	1.33e-05	0.000571	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—PRKAR2B—obesity	1.28e-05	0.000549	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—CCL5—obesity	1.28e-05	0.000546	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—PRKCD—obesity	1.27e-05	0.000542	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—NCF2—obesity	1.24e-05	0.000531	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—HTR2A—obesity	1.24e-05	0.00053	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—C3—obesity	1.24e-05	0.00053	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—NPY—obesity	1.21e-05	0.000517	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—IAPP—obesity	1.2e-05	0.000514	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—APOC3—obesity	1.2e-05	0.000514	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—AGT—obesity	1.18e-05	0.000503	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—CRH—obesity	1.17e-05	0.000499	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—HTR1B—obesity	1.17e-05	0.000499	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—SDC1—obesity	1.15e-05	0.000493	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—PRKCD—obesity	1.15e-05	0.000492	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—AKR1C3—obesity	1.13e-05	0.000485	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—HTR2A—obesity	1.13e-05	0.000482	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—C3—obesity	1.12e-05	0.000481	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—NPS—obesity	1.11e-05	0.000473	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—F2—obesity	1.09e-05	0.000465	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—PRKCB—obesity	1.09e-05	0.000465	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—HTR2C—obesity	1.08e-05	0.000464	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—DRD1—obesity	1.08e-05	0.000464	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—AGT—obesity	1.07e-05	0.000457	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—NTRK2—obesity	1.05e-05	0.000451	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—ADRB1—obesity	1.05e-05	0.000449	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—PIK3CG—obesity	1.04e-05	0.000445	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—GHRL—obesity	1.03e-05	0.00044	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—PARP1—obesity	1.03e-05	0.00044	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—DRD4—obesity	1.02e-05	0.000436	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—POMC—obesity	9.9e-06	0.000424	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—F2—obesity	9.87e-06	0.000422	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—PRKCB—obesity	9.87e-06	0.000422	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—CNR1—obesity	9.73e-06	0.000416	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—TCF7L2—obesity	9.56e-06	0.000409	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—AKT2—obesity	9.52e-06	0.000407	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—DRD2—obesity	9.5e-06	0.000406	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—PIK3CG—obesity	9.45e-06	0.000404	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—PTPN1—obesity	9.4e-06	0.000402	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—GCG—obesity	9.4e-06	0.000402	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—PIK3CD—obesity	9.15e-06	0.000391	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—POMC—obesity	8.99e-06	0.000385	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—PRL—obesity	8.97e-06	0.000384	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—STK11—obesity	8.84e-06	0.000378	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—CCL2—obesity	8.8e-06	0.000376	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—PLG—obesity	8.74e-06	0.000374	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—RHOA—obesity	8.73e-06	0.000373	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—AKT2—obesity	8.64e-06	0.00037	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—PIK3R1—obesity	8.64e-06	0.000369	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—FOXO3—obesity	8.53e-06	0.000365	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—ADRB2—obesity	8.51e-06	0.000364	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—SOCS1—obesity	8.38e-06	0.000358	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—PIK3CD—obesity	8.31e-06	0.000355	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—SOCS3—obesity	8.28e-06	0.000354	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—GNB3—obesity	8.1e-06	0.000347	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—TYK2—obesity	7.99e-06	0.000342	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—PIK3CB—obesity	7.97e-06	0.000341	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—IGF2—obesity	7.96e-06	0.00034	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—RHOA—obesity	7.92e-06	0.000339	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—GNAS—obesity	7.89e-06	0.000337	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—PIK3R1—obesity	7.84e-06	0.000335	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—APOB—obesity	7.73e-06	0.00033	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—CCL5—obesity	7.54e-06	0.000323	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—LPL—obesity	7.38e-06	0.000316	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—FOXO1—obesity	7.32e-06	0.000313	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—RPS6KB1—obesity	7.31e-06	0.000313	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—PIK3CB—obesity	7.24e-06	0.00031	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—PRKCD—obesity	6.8e-06	0.000291	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—HTR2A—obesity	6.65e-06	0.000284	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—C3—obesity	6.64e-06	0.000284	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—IRS2—obesity	6.32e-06	0.00027	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—AGT—obesity	6.31e-06	0.00027	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—LEP—obesity	6.18e-06	0.000264	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—APOE—obesity	6.18e-06	0.000264	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—CAV1—obesity	6.13e-06	0.000262	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—APOA1—obesity	6.11e-06	0.000261	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—ESR1—obesity	5.9e-06	0.000253	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—F2—obesity	5.83e-06	0.000249	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—PRKCB—obesity	5.83e-06	0.000249	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—BAD—obesity	5.76e-06	0.000246	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—PIK3CG—obesity	5.58e-06	0.000239	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—IRS1—obesity	5.52e-06	0.000236	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—POMC—obesity	5.31e-06	0.000227	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—INS—obesity	5.28e-06	0.000226	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—CCL2—obesity	5.2e-06	0.000222	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—IGF1—obesity	5.11e-06	0.000219	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—AKT2—obesity	5.11e-06	0.000218	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—PIK3CD—obesity	4.91e-06	0.00021	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—PIK3CA—obesity	4.86e-06	0.000208	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—SERPINE1—obesity	4.85e-06	0.000208	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—TYK2—obesity	4.72e-06	0.000202	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—RHOA—obesity	4.68e-06	0.0002	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—PIK3R1—obesity	4.63e-06	0.000198	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—NOS3—obesity	4.63e-06	0.000198	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—PIK3CA—obesity	4.41e-06	0.000189	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—PIK3CB—obesity	4.28e-06	0.000183	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—MTOR—obesity	4.28e-06	0.000183	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—AKT1—obesity	3.97e-06	0.00017	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—IL6—obesity	3.91e-06	0.000167	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—MMP9—obesity	3.72e-06	0.000159	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—MAPK8—obesity	3.61e-06	0.000155	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—AKT1—obesity	3.6e-06	0.000154	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—STAT3—obesity	3.3e-06	0.000141	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—MYC—obesity	3.07e-06	0.000131	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—TGFB1—obesity	3.06e-06	0.000131	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—PIK3CA—obesity	2.61e-06	0.000111	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—IL6—obesity	2.31e-06	9.87e-05	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—AKT1—obesity	2.13e-06	9.11e-05	CbGpPWpGaD
